Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Corona owner invests another $4 billion in cannabis producer Canopy

Published 08/15/2018, 01:30 PM
Updated 08/15/2018, 01:30 PM
© Reuters. FILE PHOTO: An employee holds marijuana in front of a modified Canadian flag with a marijuana leaf in Ottawa

© Reuters. FILE PHOTO: An employee holds marijuana in front of a modified Canadian flag with a marijuana leaf in Ottawa

By Uday Sampath Kumar and Nichola Saminather

(Reuters) - Corona beer maker Constellation Brands (N:STZ) will infuse another $4 billion into Canada's top cannabis producer Canopy Growth (TO:WEED), the biggest investment in the industry, to capitalize on booming demand for marijuana.

Constellation, among the first big alcohol makers to invest in the marijuana industry, pumped almost $200 million in Canopy last year in a deal to produce a non-alcoholic cannabis-based beverage.

With the new investment it will support Canopy's full suite of products and assist as it develops new offerings, Constellation Chief Executive Rob Sands said on a conference call.

Toronto-listed Canopy shares rose as much as 35 percent and were up 28 percent at C$41.17 at 10:18 am ET (1418 GMT), the highest level since June, and lifted shares of its peers. Constellation shares slid 8 percent to $203.73 in New York.

Canopy said it will use the proceeds to expand and gain exposure to the nearly 30 countries likely to approve medical marijuana. It is targeting C$1 billion in overseas acquisitions over the next six to 12 months, Canopy Chief Executive Bruce Linton said on the call.

"This (deal) marks the end of the warm-up in our sector ... It's fully go-time," Linton said.

Canada, where 4.4 million people reported using marijuana in the first half of the year, approved medical marijuana in 2001 and will fully legalize the recreational use of cannabis in October.

As some countries start opening up to legalizing medicinal marijuana, Constellation peers Molson Coors (N:TAP) and Anheuser-Busch (BR:ABI) have also pursued cannabis deals. Molson Coors said this month its Canadian arm would make cannabis-infused drinks with Hydropothecary Corp (TO:HEXO).

With its new deal, Constellation is paying a 38 percent premium to Canopy's five-day average price, taking its ownership in the company to 38 percent.

"While STZ (Constellation) is paying a rich premium ... we believe this was the right move and further solidifies STZ's first-mover advantage ...," Bonnie Herzog, a senior analyst at Wells Fargo (NYSE:WFC), said in a note.

Constellation's shares had gained 11.7 percent over the past year before the announcement, underperforming the S&P 500 index. Canopy's share price has almost tripled.

Canopy is Canada's biggest cannabis firm, with a market capitalization of C$8.9 billion ($6.76 billion).

Five of the biggest Canadian producers are now worth a total of over C$18 billion, despite low sales and almost non-existent profits, as they pour capital into increasing capacity.

Recreational use is allowed in nine U.S. states and the District of Columbia, and sales in U.S. legal markets should nearly triple to $16 billion by 2020 from $5.4 billion in 2015, according to Euromonitor International.

Constellation said neither company plans to sell cannabis products in the United States until it is allowed to do so at all government levels.

Canopy's revenue rose 63 percent to C$25.9 million in the three months ended June 30 from a year earlier. Cannabis sales volumes climbed 47 percent, while the average sale price was up 12 percent, driven by increased sales of medical marijuana in Germany, Linton said.

Constellation expects the investment in Canopy to add to earnings in 2021. The deal is expected to close in October. [nCNWc3x7ka]

The deal lifted shares of Aurora Cannabis (TO:ACB) and Aphria Inc (TO:APH), which rose 21 percent and 17 percent respectively. The ETFMG Alternative Harvest ETF, which includes U.S.- and Canadian-listed marijuana producers, rose 6.4 percent.

© Reuters. FILE PHOTO: An employee holds marijuana in front of a modified Canadian flag with a marijuana leaf in Ottawa

Latest comments

It is not an idea or a vision Elon Musk had that got the Tesla electric vehicles planned out as a future way of travel. It took years of thought, a lot of planning, hundreds of technical design drawings, knowledge and effort... which was carried out by the designer of the original electric vehicles one named TESLA after having read about the long deceased inventor, Nicholi Tesla, who lost his invention of the AC current generation method to cunning work and anti-social behavior by thieving associates he unfortunately entertained and believed in. When I was involved in the design phase of electric vehicles I as unaware of mole activity surounding my every move but, since the theft of my inventions design art and story material, the damage to my mind, spirit and soul has not destroyed me. However, my inventions are now written about favourably, watched by millions of people, a number of dogs, cats and birds. I believe The Liar Bird watches them on the television or Internet also.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.